News & Analysis on Clinical Trial Services & Contract Research And Development
This week Lonza took over the reigns of two new US business units from Cambrex after completing the largest acquisition in its company history and also announced a capability expansion at its Czech Republic site.
Inyx, Cobra and EaglePicher have all featured in new contract manufacturing announcements in the past week.
US-based sterile experts Mediatech has entered into a business agreement with US-based packaging and filling supplier Rapak to market and sell aseptic filling equipment to satisfy a gap in the market.
Indian generics company Ranbaxy Laboratories has signed a development and marketing agreement with generic injectables company Zenotech Laboratories to produce its first biosimilar, a granulocyte-colony stimulating factor (G-CSF; filgrastim), leading...
AstraZeneca's cost-cutting announcement this week could pave the way for the formation of future new outsourcing relationships.
PerkinElmer will now offer a new lab equipment relocation service to support customers who need to move and require special care for their testing and manufacturing equipment.
UK medical device firm Bespak has signed an agreement with new player Zogenix for development of a fast-acting migraine treatment.
A multinational team of researchers based in the UK has found a way to make carbon nanotubes easily cross biological barriers, opening up the potential for a new form of drug delivery.
Pharmaceutical companies manufacturing vaccines to protect against avian flu outbreaks will be protected from product liability claims according to new regulations announced by the US Department of Health and Human Services (HHS).
Swiss giant drugmaker Novartis has signed a contract deal with services provider Genpact to outsource some of its business processes to India.